BioSpace News Archive

Here, customers have the possibility to learn more about the solutions that Getinge provides to not only aid in the Coronary Artery Bypass Surgery (CABG) procedure but the entire continuum of care.

This makes the bFed System the first tube feeding delivery system to be available without a prescription.

This integration, through Apple Health, will allow users to automatically integrate their insulin data with the Glooko diabetes data management system for clinical evaluation by their healthcare professionals.

Neurodegenerative Diseases: New Insights and Therapeutic Opportunities to advance discussion about therapies for Alzheimer’s disease among world’s leading researchers

Cytonus Therapeutics Inc., a biotechnology company developing new platforms for delivering biologics, announced that it will be presenting preclinical data for its Cargocyte™ technology platform program targeting difficult to treat Breast Cancer at the BIO International Convention meeting June 3-6 in Philadelphia, PA.

Medicomp’s Quippe solution earns perfect rating on customer experience, performance, value and other criteria

Provident Healthcare Partners served as exclusive financial advisor to DEA.

Aqualung scientists identified nicotinamide phosphoribosyltransferase as a novel upstream immune-based therapeutic target in the development of Acute Respiratory Distress Syndrome, their lead clinical indication. They have developed eNamptor™, a humanized monoclonal antibody designed to neutralize circulating extracellular eNAMPT, as a novel biologic to suppress lung and systemic inflammatory cascades.

CStone Pharmaceuticals announced that it has received approval to initiate clinical development in China of CS1001 in combination with BLU-554 in patients with locally advanced or metastatic hepatocellular carcinoma.

CLS Holdings USA, Inc., the ''Company’’ or ''CLS’’, a diversified cannabis company operating as Cannabis Life Sciences, highlighted its financial and operational results for the month of May, 2019 with revenue of $1,058,867 USD.